Mild
Cognitive Impairment
Mild Cognitive Impairment (MCI) is a catch-all term for
people who show declines in their thinking abilities but whose problems
are not interfering significantly with their ability to function. Such
people may complain of problems with memory or naming or modest
confusion. Nearly 10% of persons aged 70-79 suffer from MCI and
approximately 18% of persons aged 80-89 warrant the diagnosis. Nearly
half of those who are given this diagnosis progressively deteriorate and
develop a dementia disorder within 5 years. The risk is even greater
for persons with an amnestic variant of MCI. Interventions at this
stage or even earlier are important to help maintain an individual’s
quality of life and independence for as long as possible. Thus,
accurate diagnosis of cognitive impairment at this stage is imperative.
Medication induced memory problems
Anti-depressant medications, statin drugs used to lower
cholesterol, and lipid levels, and a host of other medications can
interfere with normal cognitive function and produce impairment. The
impairment is reversible but often creates a kind of cost/benefit
paradigm for those who take these drugs between the disorders they treat
and the impact of the side effects. It is crucial to distinguish
between real cognitive degeneration and side effect induced cognitive
deficits as well as to ascertain the severity of impairment.
The
Dementias
Dementia is a general term that indicates the presence of
significant impairments in a person’s thinking and memory abilities.
These impairments are sufficiently great that they interfere with a
person’s quality of life and ability to complete daily activities. Such
impairments must include a person’s learning and memory abilities, and
at least one of the following: expressive language, nonverbal
communication, visuoperceptual abilities, and more complex, executive
functioning skills (e.g., judgment, planning, organizing, reasoning, and
problem-solving). A dementia can develop from a variety of organic
etiologies and can, in some cases, be somewhat reversible.
Alzheimer’s disease (AD)
Presently an estimated 5 million Americans suffer from
Alzheimer’s disease, characterized by neurofibrillary tangles and
neuritic plaques in the cortex of the brain. These plaques cause
progressive deterioration of the cortex. Alzheimer’s is the most common
form of dementia, and approximately one in two to three persons age 85
and older have the disease. By 2030 an estimated 7.7 million Americans
are predicted to develop the disease, a greater than 50% increase over
today’s estimates. The disease is characterized by amnestic memory
loss, in addition to problems with language, nonverbal abilities, and
more complex mental abilities. Genetics can account for some cases of
Alzheimer’s disease, but the largest risk factor for the disease is
simply age. A history of head injuries can also increase the chance of
developing the disorder. An individual with no family history of the
disease has a 15% lifetime risk of developing the disease.
Vascular Disease
Also known as multi-infarct dementia, this type of cognitive
disorder is associated with a step-wise progression of impairment, often
seen with the repeated experience of strokes or mini-strokes, causing
reduced blood flow to particular areas of the brain. This type of
dementia is typically characterized by a more subcortical pattern of
deterioration, with greater declines in attention, concentration, and
speed of thinking. Cortical abilities are generally better preserved
than in Alzheimer’s disease. Approximately 1% of persons age 60 and
older develop a vascular dementia; that rate increases to approximately
5% for individuals age 70-80.
Lewy
Body Disease
Also viewed as a generally subcortical form of dementia,
this disease is often associated with symptoms similar to Parkinson’s
disease along with other extra pyramidal symptoms. Lewy Body disease
accounts for 12 to 20% of all those diagnosed with a dementia. Visual
or auditory hallucinations and delusions are often present along with
frequent falls. Of interest is that these psychotic symptoms are often
aggravated by conventional anti-psychotic medications. Considerable
variation in cognitive functioning may be seen with this dementia as all
cases are not alike. Fluctuating attention is a core feature of this
dementia, in addition to poor nonverbal processing, and visuospatial
deficits.
Fronto-temporal disorder (FTD)
FTD, accounting for about 20% of dementia cases, typically
has an earlier onset than other forms of dementia, and the first signs
of such are typically personality and/or behavioral changes. Such
changes may include impulsivity, disinhibition, social
inappropriateness, perseveration, or apathy. This type of dementia
typically targets memory and more complex mental abilities. The frontal
and temporal lobes of the brain progressively deteriorate, while the
posterior areas of the brain are spared.
Dementia secondary to specific medical disorders
Several kinds of neurological diseases and disorders may
precipitate the development of a dementia disorder, including
Parkinson’s Disease, Huntington’s Disease, and Multiple Sclerosis. Some
rare forms of cortical brain atrophy include primary progressive aphasia
and semantic dementia (SD). SD is
a progressive neurodegenerative disorder characterized by loss of
semantic memory in both the verbal and non-verbal domains. The most
common presenting symptoms are in the verbal domain however (with loss
of word meaning).
Depression
In severely afflicted seniors depression may be mistaken for
a dementia, and it is commonly called “pseudo-dementia.” As we age the
signs and symptoms of depression can change subtly, and seniors tend to
express their mood problems with more physical complaints, such as being
exhausted yet unable to sleep or having increased pain and other somatic
problems. A loss of appetite with weight loss can occur. Depressed
seniors may also express upset about their perceived cognitive declines,
including problems with learning, memory, and attention. Depression,
though, is also a harbinger for the development of a dementia disorder,
with nearly half of seniors with Alzheimer’s disease showing symptoms of
depression two years before their diagnosis of AD. Depression may cause
neurochemical changes in the brain, which lead to deterioration and
atrophy. In some cases individuals may be developing the depression in
reaction to their own problems. In either case early accurate diagnosis
is the key to appropriate interventions in order to maintain quality of
life.
Amnesias
A particular form of Mild Cognitive Impairment, persons may
present with an inability to learn and retain new information, without
significant problems in other areas. Such a problem may be an early
sign of a developing neurodegenerative disorder or may be a pure
disorder and may occur as a result of a hypoxic or anoxic insult to the
brain.
Other
Conditions Diagnosed and Treated
Learning Disorders and Adult Attention Deficit
Learning disorders, including dyslexia, and verbal
processing disorders as well as disorders affecting mathematical
learning are life long problems that begin in childhood. People do not
“grow out” of learning disorders and may require medication and/or
tutoring to help optimize their ability to acquire new skills. Others
need professional organizers to help with executive function which
includes dealing with organization and life management skills.
In addition, the CBBS offers testing and treatment for
attention deficit disorder with and without hyperactivity for young and
middle aged adults. This disorder is most commonly discovered in
childhood and illuminated in educational settings but can be an
undiagnosed problem in adults that accounts for inability to focus, lack
of organization and impaired executive function. This problem can be
diagnosed and treated at the Center for Bio-Behavioral Science.
Center for Bio-Behavioral Science, A Medical Corporation, 2080 Century Park East #308,
Los Angeles CA 90067 Podellofcmgr@aol.com,
310-556-0970, 310-5561013 phone • 310-556-1014 fax